お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
967676

分子細胞遺伝学市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020年~2025年)

Molecular Cytogenetics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025

出版日: | 発行: IMARC Services Private Limited | ページ情報: 英文 142 Pages | 納期: 2-3営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=110.75円
分子細胞遺伝学市場:世界の業界動向、市場シェア・規模・成長率・機会・将来予測 (2020年~2025年)
出版日: 2020年10月16日
発行: IMARC Services Private Limited
ページ情報: 英文 142 Pages
納期: 2-3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の分子細胞遺伝学の市場規模は、2014年~2019年の間に約12%のCAGRで拡大しました。高齢者人口の増加や、がん・遺伝性疾患の有病率の上昇などが、市場の主な促進要因となっています。特に、比較ゲノムハイブリダイゼーション (CGH) や蛍光 in situ ハイブリダイゼーション (FISH) といった新たな検査方法が登場し、 薬理ゲノミクスのバイオマーカー研究に活用されたことで、がんの進行段階の判定や個別化医療の実現といった成果が得られています。医療インフラの大幅な改良や、生医学分野での広範・活発な研究開発 (R&D) 活動も、市場の成長促進に貢献しています。

当レポートでは、世界の分子細胞遺伝学市場の構造と動向について分析し、市場の全体的構造や、市場規模の推移・予測、製品種類別・技術別・用途別・エンドユーザー別・地域別の詳細動向、市場の求心力・競争情勢、主要企業のプロファイルなどについて調査しております。

目次

第1章 序論

第2章 分析範囲・手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

第5章 世界の分子細胞遺伝学市場

  • 市場概要
  • 市場規模の実績値
  • 新型コロナウイルス感染症 (COVID-19) の影響

第6章 製品種類別の市場区分

  • 医療機器
  • 消耗品
  • ソフトウェア・サービス
  • その他

第7章 技術別の市場区分

  • 比較ゲノムハイブリダイゼーション (CGH)
  • 蛍光 in situ ハイブリダイゼーション (FISH)
  • 免疫組織化学
  • 核型分析
  • その他

第8章 用途別の市場区分

  • 遺伝性疾患
  • 腫瘍
  • 個別化医療
  • その他

第9章 エンドユーザー別の市場区分

  • 臨床検査室・研究所
  • 病院・病理研究所
  • 製薬企業・バイオテクノロジー企業
  • その他

第10章 地域別の市場区分

  • 北米
    • 米国
    • カナダ
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 国別の市場崩壊

第11章 SWOT分析

第12章 バリューチェーン分析

第13章 ポーターズファイブフォース分析

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abbott Laboratories
    • Agilent Technologies Inc.
    • Applied Spectral Imaging Inc.
    • Biological Industries
    • Bio-RAD Laboratories Inc.
    • BioView Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • Oxford Gene Technology
    • Perkinelmer Inc.
    • Quest Diagnostics Incorporated
図表

List of Figures

  • Figure 1: Global: Molecular Cytogenetics Market: Major Drivers and Challenges
  • Figure 2: Global: Molecular Cytogenetics Market: Sales Value (in Billion US$), 2014-2019
  • Figure 3: Global: Molecular Cytogenetics Market: Breakup by Product Type (in %), 2019
  • Figure 4: Global: Molecular Cytogenetics Market: Breakup by Technology (in %), 2019
  • Figure 5: Global: Molecular Cytogenetics Market: Breakup by Application (in %), 2019
  • Figure 6: Global: Molecular Cytogenetics Market: Breakup by End User (in %), 2019
  • Figure 7: Global: Molecular Cytogenetics Market: Breakup by Region (in %), 2019
  • Figure 8: Global: Molecular Cytogenetics Market Forecast: Sales Value (in Billion US$), 2020-2025
  • Figure 9: Global: Molecular Cytogenetics (Instruments) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 10: Global: Molecular Cytogenetics (Instruments) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 11: Global: Molecular Cytogenetics (Consumables) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 12: Global: Molecular Cytogenetics (Consumables) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 13: Global: Molecular Cytogenetics (Software and Services) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 14: Global: Molecular Cytogenetics (Software and Services) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 15: Global: Molecular Cytogenetics (Other Product Types) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 16: Global: Molecular Cytogenetics (Other Product Types) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 17: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 18: Global: Molecular Cytogenetics (Comparative Genomic Hybridization) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 19: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 20: Global: Molecular Cytogenetics (Fluorescence in SITU Hybridization - FISH) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 21: Global: Molecular Cytogenetics (Immunohistochemistry) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 22: Global: Molecular Cytogenetics (Immunohistochemistry) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 23: Global: Molecular Cytogenetics (Karyotyping) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 24: Global: Molecular Cytogenetics (Karyotyping) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 25: Global: Molecular Cytogenetics (Other Technologies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 26: Global: Molecular Cytogenetics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 27: Global: Molecular Cytogenetics (Genetic Disorders) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 28: Global: Molecular Cytogenetics (Genetic Disorders) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 29: Global: Molecular Cytogenetics (Oncology) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 30: Global: Molecular Cytogenetics (Oncology) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 31: Global: Molecular Cytogenetics (Personalized Medicine) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 32: Global: Molecular Cytogenetics (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 33: Global: Molecular Cytogenetics (Other Applications) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 34: Global: Molecular Cytogenetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 35: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 36: Global: Molecular Cytogenetics (Clinical and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 37: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 38: Global: Molecular Cytogenetics (Hospitals and Pathology Laboratories) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 39: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 40: Global: Molecular Cytogenetics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 41: Global: Molecular Cytogenetics (Other End Users) Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 42: Global: Molecular Cytogenetics (Other End Users) Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 43: North America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 44: North America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 45: United States: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 46: United States: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 47: Canada: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 48: Canada: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 49: Asia Pacific: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 50: Asia Pacific: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 51: China: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 52: China: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 53: Japan: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 54: Japan: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 55: India: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 56: India: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 57: South Korea: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 58: South Korea: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 59: Australia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 60: Australia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 61: Indonesia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 62: Indonesia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 63: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 64: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 65: Europe: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 66: Europe: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 67: Germany: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 68: Germany: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 69: France: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 70: France: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 71: United Kingdom: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 72: United Kingdom: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 73: Italy: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 74: Italy: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 75: Spain: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 76: Spain: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 77: Russia: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 78: Russia: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 79: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 80: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 81: Latin America: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 82: Latin America: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 83: Brazil: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 84: Brazil: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 85: Mexico: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 86: Mexico: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 87: Others: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 88: Others: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 89: Middle East and Africa: Molecular Cytogenetics Market: Sales Value (in Million US$), 2014 & 2019
  • Figure 90: Middle East and Africa: Molecular Cytogenetics Market Forecast: Sales Value (in Million US$), 2020-2025
  • Figure 91: Global: Molecular Cytogenetics Industry: SWOT Analysis
  • Figure 92: Global: Molecular Cytogenetics Industry: Value Chain Analysis
  • Figure 93: Global: Molecular Cytogenetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Molecular Cytogenetics Market: Key Industry Highlights, 2019 and 2025
  • Table 2: Global: Molecular Cytogenetics Market Forecast: Breakup by Type (in Million US$), 2020-2025
  • Table 3: Global: Molecular Cytogenetics Market Forecast: Breakup by Technology (in Million US$), 2020-2025
  • Table 4: Global: Molecular Cytogenetics Market Forecast: Breakup by Application (in Million US$), 2020-2025
  • Table 5: Global: Molecular Cytogenetics Market Forecast: Breakup by End User (in Million US$), 2020-2025
  • Table 6: Global: Molecular Cytogenetics Market Forecast: Breakup by Region (in Million US$), 2020-2025
  • Table 7: Global: Molecular Cytogenetics Market Structure
  • Table 8: Global: Molecular Cytogenetics Market: Key Players
目次
Product Code: SR1019N17_Report

The global molecular cytogenetics market grew at a CAGR of around 12% during 2014-2019. Molecular cytogenetics refers to the biomedical research of deoxyribonucleic acid (DNA) mechanisms to investigate genetic mutations and disorders. It studies the structural and functional organization of the chromosomes and their nucleus, genomic variations, expression, evolution and abnormalities, especially in medicinal and cancer-related genetics. Techniques such as DNA amplification, DNA isolation, gene screens, virtual karyotyping and fluorescence in situ hybridization (FISH) are commonly used for molecular cytogenetics by using DNA probes to visualize and label the genome or its targeted regions. These techniques are highly beneficial in the diagnosis and treatment of various malignant tumors and hematological malignancies.

The increasing prevalence of cancer and other genetic disorders, along with the rising geriatric population, is one of the key factors driving the growth of the market. Molecular cytogenetics is primarily being used for developing predictive models of disease traits and effective treatment strategies. Furthermore, the widespread adoption of targeted therapies for cancer treatment is also augmenting the market growth. FISH and Comparative Genomic Hybridization (CGH) are also used for pharmacogenomic biomarker studies to analyze cancer progression stages and provide personalized treatment to the patient. Additionally, various technological advancements, such as the development of improved consumables, reagents, software and kits, are acting as other growth-inducing factors. These advancements aid in generating duplicatable, accurate and reliable clinical-pathological test results. Other factors, including significant improvements in the healthcare infrastructure, along with extensive research and development (R&D) activities in the field of biomedical sciences, are anticipated to drive the market further. Looking forward, IMARC Group expects the global molecular cytogenetics market to continue its strong growth during the next five years.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global molecular cytogenetics market report, along with forecasts for growth at the global, regional and country level from 2020-2025. Our report has categorized the market based on region, product type, technology, application and end user.

Breakup by Product Type:

  • Instruments
  • Consumables
  • Software and Services
  • Others

Breakup by Technology:

  • Comparative Genomic Hybridization
  • Fluorescence in SITU Hybridization (FISH)
  • Immunohistochemistry
  • Karyotyping
  • Others

Breakup by Application:

  • Genetic Disorders
  • Oncology
  • Personalized Medicine
  • Others

Breakup by End User:

  • Clinical and Research Laboratories
  • Hospitals and Pathology Laboratories
  • Pharmaceutical and Biotechnology Companies
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Agilent Technologies Inc., Applied Spectral Imaging Inc., Biological Industries, Bio-RAD Laboratories Inc., BioView Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., Oxford Gene Technology, Perkinelmer Inc. and Quest Diagnostics Incorporated.

Key Questions Answered in This Report:

  • How has the global molecular cytogenetics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global molecular cytogenetics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global molecular cytogenetics market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Molecular Cytogenetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Instruments
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Consumables
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Software and Services
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Others
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Comparative Genomic Hybridization
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Fluorescence in SITU Hybridization (FISH)
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Immunohistochemistry
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Karyotyping
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Genetic Disorders
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Oncology
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Personalized Medicine
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Clinical and Research Laboratories
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Pathology Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Agilent Technologies Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Applied Spectral Imaging Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Biological Industries
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 BioView Inc.
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Danaher Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 F. Hoffmann-La Roche AG
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 SWOT Analysis
    • 15.3.9 Illumina Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Oxford Gene Technology
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Perkinelmer Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Quest Diagnostics Incorporated
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.